The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-6-(3-aminopropoxy)-1-ethyl-1H-imidazo[4,5-c]pyridin-4-yl)-2-methylbut-3-yn-2-ol ID: ALA1096292
PubChem CID: 11959550
Max Phase: Preclinical
Molecular Formula: C18H23N7O3
Molecular Weight: 385.43
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCCN)cc21
Standard InChI: InChI=1S/C18H23N7O3/c1-4-25-12-10-13(27-9-5-8-19)21-11(6-7-18(2,3)26)14(12)22-17(25)15-16(20)24-28-23-15/h10,26H,4-5,8-9,19H2,1-3H3,(H2,20,24)
Standard InChI Key: AZQPVODZWGLBAX-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 30 0 0 0 0 0 0 0 0999 V2000
14.4232 -16.2016 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.4230 -17.0266 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1374 -17.4392 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1372 -18.2642 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8516 -18.6769 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.1908 -15.3936 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6963 -14.7372 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9158 -15.0075 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.9332 -15.8335 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.7243 -16.0709 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.9368 -13.9481 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.0143 -15.3777 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9914 -16.2027 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7078 -15.7894 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7050 -14.9588 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.9896 -14.5497 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4947 -16.0393 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.2766 -15.7898 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2792 -14.9676 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4974 -14.7124 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.4714 -16.8640 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7456 -17.2562 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9845 -13.7247 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9792 -12.8958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9750 -12.0708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6874 -11.6547 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.2585 -11.6619 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9708 -11.2458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14 15 1 0
4 5 1 0
15 16 2 0
16 19 1 0
18 19 2 0
6 7 1 0
8 9 1 0
9 10 1 0
10 6 2 0
17 18 1 0
19 20 1 0
20 12 2 0
12 17 1 0
2 3 1 0
17 21 1 0
7 11 1 0
21 22 1 0
7 8 2 0
16 23 1 0
6 12 1 0
23 24 3 0
1 2 1 0
24 25 1 0
18 13 1 0
25 26 1 0
3 4 1 0
25 27 1 0
13 14 2 0
25 28 1 0
14 1 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 385.43Molecular Weight (Monoisotopic): 385.1862AlogP: 0.93#Rotatable Bonds: 6Polar Surface Area: 151.13Molecular Species: BASEHBA: 10HBD: 3#RO5 Violations: ┄HBA (Lipinski): 10HBD (Lipinski): 5#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.26CX Basic pKa: 9.94CX LogP: 0.88CX LogD: -1.54Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.42Np Likeness Score: -0.84
References 1. Rouse MB, Seefeld MA, Leber JD, McNulty KC, Sun L, Miller WH, Zhang S, Minthorn EA, Concha NO, Choudhry AE, Schaber MD, Heerding DA.. (2009) Aminofurazans as potent inhibitors of AKT kinase., 19 (5): [PMID:19179070 ] [10.1016/j.bmcl.2009.01.002 ]